$7.4 million in cash expected to provide runway to complete site expansion process and patient enrollment as part of ...
Quarterly Revenue Growth Driven by Amtagvi DemandGross Margin Increased to 50% FY25 Revenue of $264M Achieved Annual Guidance U.S. FDA Fast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results